RLFTF — MindMaze Therapeutics Holding SA

OTC · Health Care · Pharmaceuticals · CIK 1854078 · Switzerland
Last close
$0.51
Market Cap
$6.37M
52W High
$0.93
52W Low
$0.33
ADV30
3,880
Next earnings
MindMaze Therapeutics Holding SA operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally. The company offers MindPod system, a supervised in-clinic neurorehabilitation system designed to initiate and intensify the recovery journey; MindMotion GO, which extends protocolized neurotherapeutics into outpatient and home settings; MindMotion Companion, an application that manages prescription, monitoring and documentation across MindMaze Therapeutics' neurotherapeutics ecosystem; and the patient app, a patient-facing mobile application, that supports clinic-to-home continuity by making prescribed therapy easy to follow outside the clinic. It also provides Izar hand therapy device which supports fine motor rehabilitation; Physilog sensor, a wearable inertial sensing device designed to quantify human movement; toaprun, a training for Parkinson's therapy-reimagined through play. The company was founded in 2012 and is headquartered in Geneva, Switzerland.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Jun 2025 47,987,000 12,500,000 15,354,000
Dec 2024 53,224,000 15,080,000 16,560,000

Balance + Analyst (yfinance extras)

Retained Earnings
$-240,222,000
Inventory
$923,000
Receivables
$1,468,000
ST Investments
EBIT TTM
Pretax Income TTM
Interest Exp TTM
Analysts

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2024 8,417,000 -7,906,000 -17,119,000 53,224,000 16,560,000 -2,916,000
Dec 2023 6,033,000 -19,778,000 -98,181,000 76,390,000 24,162,000 -17,612,000
Dec 2022 6,081,000 -35,474,000 -50,790,000 188,798,000 43,381,000 -24,126,000
Dec 2021 3,321,000 -34,611,000 -34,705,000 251,618,000 70,088,000 -35,718,000

Peers — same industry

TickerNameMarket CapLastDaily %
ASBP Aspire Biopharma Holdings, Inc. $6.57M $5.07
APVO Aptevo Therapeutics Inc. $6.09M $4.89
SILO Silo Pharma, Inc. $6.69M $0.41
SBFM Sunshine Biopharma Inc. $6.73M $0.42
TCRT Alaunos Therapeutics, Inc. $5.98M $2.45

News headlines (Yahoo Finance, 1h cache)

MindMaze Therapeutics Announces CHF 8.0 Million Strategic Equity Financing
2026-05-26 05:50 · Yahoo
MindMaze Therapeutics and Vibra Healthcare Sign Definitive Channel Partnership Agreement to Scale Advanced Neurotherapeutics Across the U.S.
2026-05-12 05:25 · Yahoo
MindMaze Therapeutics Announces Initiation of Coverage by Baader Bank
2026-03-19 06:35 · Yahoo
MindMaze Therapeutics Appoints HealthTech Veteran Zach Henderson as CEO to Accelerate Global Commercial Scale
2026-03-12 07:44 · Yahoo
MindMaze Therapeutics Provides Corporate Update and Publishes March 2026 Investor Presentation
2026-03-03 07:45 · Yahoo
MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics
2025-12-23 06:20 · Yahoo
Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics
2025-12-15 06:20 · Yahoo
Relief Therapeutics Shareholders Approve Business Combination with NeuroX
2025-11-14 17:40 · Yahoo
Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032
2025-10-29 06:20 · Yahoo
Relief Therapeutics Publishes 2025 Half-Year Report
2025-08-14 05:20 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.